Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Tumour-associated macrophages (TAMs) are enriched in glioblastoma multiformes (GBMs) that contain glioma stem cells (GSCs) at the apex of their cellular hierarchy. The correlation between TAM density and glioma grade suggests a supportive role for TAMs in tumour progression. Here we interrogated the molecular link between GSCs and TAM recruitment in GBMs and demonstrated that GSCs secrete periostin (POSTN) to recruit TAMs. TAM density correlates with POSTN levels in human GBMs. Silencing POSTN in GSCs markedly reduced TAM density, inhibited tumour growth, and increased survival of mice bearing GSC-derived xenografts. We found that TAMs in GBMs are not brain-resident microglia, but mainly monocyte-derived macrophages from peripheral blood. Disrupting POSTN specifically attenuated the tumour-supportive M2 type of TAMs in xenografts. POSTN recruits TAMs through the integrin αvβ₃ as blocking this signalling by an RGD peptide inhibited TAM recruitment. Our findings highlight the possibility of improving GBM treatment by targeting POSTN-mediated TAM recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Periostin (Postn) is shown to be required for alternative (less inflammatory) activation of microglia in brain tumors (Zhou et al., 2015).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“TD2 genes were well characterized for regulation of phagocytosis and microglial activation (e.g. Lgasl3; Rotshenker, 2009), microglial survival (e.g. Spp1; Rabenstein et al., 2016), alternative M2 activation of microglia (Zhou et al., 2015), and lysosomal proton pump (Atp6v0d2).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Zhou et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Crypt stem cells as the cells-of-origin of intestinal cancer
Barker, N., Ridgway, R. A., van Es, J. H., van de Wetering, M., Begthel, H., van den Born, M., Danenberg, E., Clarke, A. R., Sansom, O. J., & Clevers, H. (2009) · Nature · doi:10.1038/nature07602 · Cited by 2,166
Research works printed but not linked: 1
- Cheng L Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth Cell 153 139 152 2013 23540695 PMC3638263
Cited by
Items 301–400 of 942
Control of brain tumor growth by reactivating myeloid cells with niacin
Sarkar, S., Yang, R., Mirzaei, R., Rawji, K. S., Poon, C. C., Mishra, M. K., Zemp, F. J., Bose, P., Kelly, J. J., Dunn, J. F., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay9924 · Cited by 55
A unified model of the hierarchical and stochastic theories of gastric cancer
Song, Y., Wang, Y., Tong, C., Xi, H., Zhao, X., Wang, Y., & Chen, L. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.54 · Cited by 60
“The other essential aspects of the CSC niche, such as hypoxia (Lu et al, 2015; Zhang et al, 2016a), tumour-associated macrophages (Wan et al, 2014; Zhou et al, 2015; Jia et al, 2016; Raggi et al, 2016), blood vessels (Borovski et al, 2011) and vasculogenic mimicry (Sun et al, 2016), have also been…”
BackgroundGlioblastoma Immunotherapy Targeting the Innate Immune Checkpoint CD47-SIRPα Axis
Hu, J., Xiao, Q., Dong, M., Guo, D., Wu, X., & Wang, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.593219 · Cited by 56
“Approximately 85% of them are bone marrow-derived infiltrating macrophages/monocytes while the remaining fractions are locally resident microglia (12, 13), which engage in reciprocal interactions with GBM and adaptive immune”
BackgroundXu, X., Chang, W., Yuan, J., Han, X., Tan, X., Ding, Y., Luo, Y., Cai, H., Liu, Y., Gao, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5985 · Cited by 53
“com/oncotarget of stromal POSTN and POSTN derived from cancer stem cells can recruit M2 tumor-associated macrophages and promotes malignant growth [35, 36], indicating that POSTN bridges cancer cells and cancer-supportive stromal cells.”
BackgroundShort Peptides Interfering with Signaling Pathways as New Therapeutic Tools for Cancer Treatment
Ellert‐Miklaszewska, A., Poleszak, K., & Kaminska, B. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0189 · Cited by 54
Torres, M. M., Wang, J., Yannie, P. J., Ghosh, S., Segal, R. A., & Reynolds, A. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007172 · Cited by 62
Xu, H., Li, T., Wang, C., Ma, Y., Liu, Y., Zheng, M.-Y., Liu, Z.-J.-Y., Chen, J., Li, K., Sun, S., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01017-w · Cited by 57
Ervin, E.-H., French, R., Chang, C., & Pauklin, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.11.001 · Cited by 56
Hu, K. H., Kuhn, N. F., Courau, T., Tsui, J. L., Samad, B., Ha, P. K., Kratz, J. R., Combes, A. J., & Krummel, M. F. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.05.001 · Cited by 57
Impact of mesenchymal stem cells’ secretome on glioblastoma pathophysiology
de Castro, J. V., Gomes, E. D., Granja, S., Anjo, S. I., Baltazar, F., Manadas, B. J., Salgado, A. J., & Costa, B. M. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1303-8 · Cited by 51
Yuan, D., Tao, Y., Chen, G., & Shi, T. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0363-1 · Cited by 57
“CSCs of gliomas were also found to recruit TAMs by secreting POSTN to support the growth of glioblastoma (GBM) [18].”
BackgroundGlioblastoma Stem Cells—Useful Tools in the Battle against Cancer
Rodriguez, S. M. B., Staicu, G.-A., Sevastre, A.-S., Baloi, C., Ciubotaru, V. G., Dricu, A., & Tătăranu, L. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094602 · Cited by 61
Verona, F., Bella, S. D., Schirano, R., Manfredi, C., Angeloro, F., Bozzari, G., Todaro, M., Giannini, G., Stassi, G., & Veschi, V. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1529847 · Cited by 56
Microglia-glioblastoma interactions: New role for Wnt signaling
Matias, D., Predes, D., Filho, P. N., Lopes, M. C., Abreu, J. G., Lima, F. R. S., & Moura‐Neto, V. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.05.007 · Cited by 52
Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells
Alhabbab, R. Y. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00312 · Cited by 53
Modeling the Interaction between the Microenvironment and Tumor Cells in Brain Tumors
Pasqualini, C., Kozaki, T., Bruschi, M., Nguyen, T. H. H., Minard‐Colin, V., Castel, D., Grill, J., & Ginhoux, F. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.018 · Cited by 59
FGL2-wired macrophages secrete CXCL7 to regulate the stem-like functionality of glioma cells
Yan, J., Zhao, Q., Wang, J., Tian, X., Wang, J., Xia, X., Ott, M., Rao, G., Heimberger, A. B., & Li, S. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.02.021 · Cited by 52
Gliomagenesis mimics an injury response orchestrated by neural crest-like cells
Hamed, A. A., Hua, K., Trinh, Q. M., Simons, B. D., Marioni, J. C., Stein, L. D., & Dirks, P. B. (2025) · Nature · doi:10.1038/s41586-024-08356-2 · Cited by 52
Zanganeh, S., Spitler, R., Hütter, G., Ho, J. Q., Pauliah, M., & Mahmoudi, M. (2017) · Immunotherapy · doi:10.2217/imt-2017-0041 · Cited by 49
PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas
Zhang, H., He, J., Dai, Z., Wang, Z., Liang, X., He, F., Xia, Z., Feng, S., Cao, H., Zhang, L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.628966 · Cited by 62
BRD4: New hope in the battle against glioblastoma
Duan, W., Yu, M., & Chen, J. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106767 · Cited by 51
Elechalawar, C. K., Bhattacharya, D., Ahmed, M. T., Ravuri, H. G., Sridharan, K., Chaturbedy, P., Sinha, S. H., Jaggarapu, M. M. C. S., Narayan, K. P., Chakravarty, S., et al. (2019) · Nanoscale Advances · doi:10.1039/c9na00056a · Cited by 51
Chen, G., Wang, Y., Zhao, X., Xie, X., Zhao, J., Deng, T., Chen, Z., Chen, H., Tong, Y., Yang, Z. F., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02011-8 · Cited by 53
“shown that the POSTN protein plays a vital role in the formation and maintenance of the stemness-enhancing microenvironment of tumours, thus promoting tumour metastasis and invasion [15].”
BackgroundRusso, M. N., Whaley, L. A., Norton, E. S., Zarco, N., & Guerrero‐Cazares, H. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101167 · Cited by 52
Natural Killer Cell-Based Immunotherapy against Glioblastoma
Morimoto, T., Nakazawa, T., Maeoka, R., Nakagawa, I., Tsujimura, T., & Matsuda, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032111 · Cited by 54
Tumor-associated myeloid cells as guiding forces of cancer cell stemness
Sica, A., Porta, C., Amadori, A., & Pastò, A. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-1997-8 · Cited by 50
“1 3 T regulatory/cytotoxic T-cell ratio [66] and M2-TAM accumulation [57].”
BackgroundAn emerging role for cellular crosstalk in the cancer stem cell niche
Oshimori, N., Guo, Y., & Taniguchi, S. (2021) · The Journal of Pathology · doi:10.1002/path.5655 · Cited by 51
“Depleting periostin in CSCs reduced TAMdensity, attenuated alternatively activated phenotypes, and increased survival of mice bearing glioblastoma [66].”
BackgroundYang, M., Wang, B., Yin, Y., Ma, X., Tang, L., Zhang, Y., Fan, Q., Yin, T., & Wang, Y. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.11.025 · Cited by 49
Reinventing the human tuberculosis (TB) granuloma: Learning from the cancer field
Ashenafi, S., & Brighenti, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1059725 · Cited by 52
“TAMs are the most abundant population of tumor-infiltrating immune cells in the TME (38) and typically belong to the M2-like macrophage population (29, 39) that are associated with poor prognosis in different cancers (40, 41).”
BackgroundThe diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma
Zhang, L., Jiang, Y., Zhang, G., & Wei, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1238233 · Cited by 56
Tang, M., Liu, B., Bu, X., & Zhao, P. (2018) · Cancer Science · doi:10.1111/cas.13567 · Cited by 46
JAM-A functions as a female microglial tumor suppressor in glioblastoma
Turaga, S. M., Silver, D. J., Bayık, D., Paouri, E., Peng, S., Lauko, A. J., Alban, T. J., Borjini, N., Stanko, S., Naik, U. P., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa148 · Cited by 47
de Castro, J. V., Gonçalves, C. S., Hormigo, A., & Costa, B. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155278 · Cited by 51
Tagde, P., Tagde, P., Tagde, S., Bhattacharya, T., Garg, V., Akter, R., Rahman, M. H., Najda, A., Albadrani, G. M., Sayed, A. A., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111928 · Cited by 51
RetractedPeriostin Limits Tumor Response to VEGFA Inhibition
Keklikoglou, I., Kadioglu, E., Bissinger, S., Langlois, B., Bellotti, A., Orend, G., Ries, C. H., & Palma, M. D. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.035 · Cited by 47
Leukotriene B4 promotes neovascularization and macrophage recruitment in murine wet-type AMD models
Sasaki, F., Koga, T., Ohba, M., Saeki, K., Okuno, T., Ishikawa, K., Nakama, T., Nakao, S., Yoshida, S., Ishibashi, T., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.96902 · Cited by 45
CDK5 Inhibition Abrogates TNBC Stem‐Cell Property and Enhances Anti‐PD‐1 Therapy
Bei, Y., Cheng, N., Chen, T., Shu, Y., Yang, Y., Yang, N., Zhou, X., Liu, B., Wei, J., Liu, Q., et al. (2020) · Advanced Science · doi:10.1002/advs.202001417 · Cited by 48
The Impact of Metabolic Rewiring in Glioblastoma: The Immune Landscape and Therapeutic Strategies
Vijayanathan, Y., & Ho, I. A. W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020669 · Cited by 52
Targeting the perivascular niche in brain tumors
Seano, G. (2017) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000417 · Cited by 46
Niu, B., Liang, C., Lu, Y., Zhao, M., Chen, Q., Zhang, Y., Zheng, L., & Chou, K. (2019) · Genomics · doi:10.1016/j.ygeno.2019.05.024 · Cited by 46
Davidov, V., Jensen, G. L., Mai, S., Chen, S., & Pan, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01842 · Cited by 47
“The contribution of various myeloid cell ontologies to tumor development and immunosuppression is highly debated (51), although myeloid cells recruited from the periphery seemingly have a more important role in propagating the growth and invasiveness of malignancies (17, 52).”
BackgroundZhang, W., & Huang, X. (2025) · Biomarker Research · doi:10.1186/s40364-025-00750-w · Cited by 51
Lu, C., Kang, T., Zhang, J., Yang, K., Liu, Y., Song, K., Lin, Q., Dixit, D., Gimple, R. C., Zhang, Q., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58366-5 · Cited by 61
“Interactions between GSCs and tumor immune microenvironment are closely related to GBM malignant progression 25,26 .”
Uneda, A., Kurozumi, K., Fujimura, A., Fujii, K., Ishida, J., Shimazu, Y., Otani, Y., Tomita, Y., Hattori, Y., Matsumoto, Y., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01124-7 · Cited by 52
“GSCs recruit monocytederived macrophages from peripheral blood through paracrine periostin and osteopontin signaling [46, 58, 63].”
BackgroundNT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn
Guo, S., Ran, H., Xiao, D., Huang, H., Mi, L., Wang, X., Chen, L., Li, D., Zhang, S., Han, Q., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.003 · Cited by 44
Personalizing Oncolytic Virotherapy for Glioblastoma: In Search of Biomarkers for Response
Stavrakaki, Ε., Dirven, C. M. F., & Lamfers, M. L. M. (2021) · Cancers · doi:10.3390/cancers13040614 · Cited by 47
“When monocytes arrive at the tumor site, glioma cells drive their polarization to an immunosuppressive M2 phenotype [44,45].”
BackgroundWu, Y., Rong, X., Pan, M., Wang, T., Yang, H., Chen, X., Xiao, Z., & Zhao, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.840171 · Cited by 52
“Previous studies confirmed that Postn is closely related to cancer progression and may promote tumor invasion through the ILK (Integrin-linked protein kinase)/RAC-alpha serine (AKT)/Serine/threonineprotein kinase mTOR (mTOR) pathway (Zhou et al., 2015; Chen et al., 2020; Jia et al., 2021).”
BackgroundMicroglia and Brain Macrophages as Drivers of Glioma Progression
Zheng, Y., & Graeber, M. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415612 · Cited by 42
Wei, T., Wang, K., Liu, S., Fang, Y., Hong, Z., Liu, Y., Zhang, H., Yang, C. J., Ouyang, G., & Wu, T. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112090 · Cited by 43
You, T., Tang, H. J., Wu, W., Gao, J., Li, X., Li, N., Xu, X., Xing, J., Ge, H., Xiao, Y., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0503 · Cited by 48
“Previous studies have suggested that POSTN secreted by glioblastoma stem cells activates the Akt signalling pathway in macrophages through integrin αvβ3 signalling, leading to macrophage chemotaxis [26].”
BackgroundInfluentialHung, N. A., Eiholzer, R. A., Kirs, S., Zhou, J., Ward‐Hartstonge, K. A., Wiles, A. K., Frampton, C. M., Taha, A. J., Royds, J. A., & Slatter, T. L. (2016) · Modern Pathology · doi:10.1038/modpathol.2015.156 · Cited by 47
Lu, L., Shen, X., Tao, B., Lin, C., Li, K., Luo, Z. Y., & Cai, K. (2019) · Journal of Materials Chemistry B · doi:10.1039/c8tb03165g · Cited by 44
Yoo, K.-C., Kang, J.-H., Choi, M. K., Suh, Y., Zhao, Y., Kim, M., Chang, J. H., Shim, J., Yoon, S., Kang, S., et al. (2021) · Advanced Science · doi:10.1002/advs.202102768 · Cited by 42
Nunomura, S., Uta, D., Kitajima, I., Nanri, Y., Matsuda, K., Ejiri, N., Kitajima, M., Ikemitsu, H., Koga, M., Yamamoto, S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2022.111933 · Cited by 42
“39,40 Therefore, periostin may be involved in the infiltration of M2 macrophages by either enhancing M2 polarization or recruitment of M2 macrophages independently of IL-4 and IL-13.”
Liu, H., Wu, Q., Liu, L., Liu, L., He, Z. M., Liu, Y., Sun, Y., Liu, X., & Luo, E. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122406 · Cited by 45
Differential Characterization of Temozolomide-Resistant Human Glioma Cells
Lai, S., Huang, B., Liu, Y.-S., Lin, H., Chen, C.-C., Tsai, C., Lu, D., & Lin, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010127 · Cited by 40
“Importantly, a recent report and a clinical study revealed that those monocytes/macrophages are the most predominant tumor-associated macrophages (TAMs) in GBM [32,33].”
BackgroundPeripheral blood test provides a practical method for glioma evaluation and prognosis prediction
Wang, Z., Zhang, C., Liu, Y., Wang, Z., & Jiang, T. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13120 · Cited by 43
Pileri, A., Guglielmo, A., Grandi, V., Violetti, S. A., Fanoni, D., Fava, P., Agostinelli, C., Berti, E., Quaglino, P., & Pimpinelli, N. (2021) · Cells · doi:10.3390/cells10102780 · Cited by 47
“[71] evaluated the activity of macrophages in each stage of MF, from the early stage to the tumor stage, and the role of periostin, an extracellular matrix protein that is known to be involved in the recruitment of Th2 cells and the polarization of M2 macrophages in the tumor microenvironment [72,73].”
BackgroundLu, L., Wang, K., Lin, C., Yang, W., Duan, Q., Li, K., & Cai, K. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121193 · Cited by 41
p73 promotes glioblastoma cell invasion by directly activating POSTN (periostin) expression
Landré, V., Antonov, A. V., Knight, R. A., & Melino, G. (2016) · Oncotarget · doi:10.18632/oncotarget.7600 · Cited by 42
“We chose POSTN (Periostin), as it has previously been implicated in glioblastoma malignancy and to be important for EMT and cancer metastasis [96-98].”
MethodThe Multiaspect Functions of Periostin in Tumor Progression
Liu, Y., Huang, Z., Cui, D., & Ouyang, G. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-6657-4_13 · Cited by 43
A Risk Classification System With Five-Gene for Survival Prediction of Glioblastoma Patients
Wang, Y., Liu, X., Guan, G., Zhao, W., & Zhuang, M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00745 · Cited by 45
“It has also been reported that POSTN recruits M2 tumor-associated macrophages and promotes glioma stem cells (GSCs) growth (30).”
BackgroundMiyazaki, T., Ishikawa, E., Sugii, N., & Matsuda, M. (2020) · Cancers · doi:10.3390/cancers12071960 · Cited by 44
“As for humoral factors, VEGF [34], macrophage migration inhibitory factor (MIF) [35], IL-6 [29], IL-4 / 13 [36,37], IL-10, TGF β [38], POSTN [39], colony-stimulating factor-1 (CSF-1) [40], CCL2 [41], CXCL12 [42], and COX-2 / PGE2 [43] directly or indirectly regulate the immunosuppressive tumor…”
Incorporating Tumor-Associated Macrophages into Engineered Models of Glioma
Akins, E. A., Aghi, M. K., & Kumar, S. (2020) · iScience · doi:10.1016/j.isci.2020.101770 · Cited by 47
TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas
Chen, R., Wang, X., Dai, Z., Wang, Z., Wu, W., Hu, Z., Zhang, X., Liu, Z., Zhang, H., & Cheng, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.713757 · Cited by 45
“Metabolites produced by malignant cells would lead to the M2 polarization of macrophages and generate multiple cytokines and angiogenic factors, and this process ends up inducing the progression and invasion of tumor (74, 75).”
BackgroundInteraction of tumor-associated microglia/macrophages and cancer stem cells in glioma
Zhu, X., Fang, Y., Chen, Y., Chen, Y., Hong, W., Wei, W., & Tu, J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121558 · Cited by 42
Caverzán, M. D., Beaugé, L., Oliveda, P. M., Cesca, B. A., Bühler, E. M., & Ibarra, L. E. (2023) · Brain Sciences · doi:10.3390/brainsci13040542 · Cited by 47
“Additionally, it was shown with orthotopic GSC x nografts that periostin secreted by tumor cells specifically supported the re ruitment of nti-inflammatory and consequently pro-tumor monocyte-derived m crophages, a result validated with immunohi tochemistry on huma GBM tissue, which showed more CCR2+ cells in the tumo…”
ResultBeyond the M‐ CSF receptor – novel therapeutic targets in tumor‐associated macrophages
Bonelli, S., Geeraerts, X., Bolli, E., Keirsse, J., Kiss, M., Antunes, A. R. P., Damme, H. V., Vlaminck, K. D., Movahedi, K., Laoui, D., et al. (2017) · FEBS Journal · doi:10.1111/febs.14202 · Cited by 42
Wang, S., Liu, X., Huang, R., Zheng, Y., Wang, N., Yang, B., Situ, H., Lin, Y. H., & Wang, Z. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01371 · Cited by 39
“With regard to TAMs, it was reported that multiple factors including CSF-1 and CCL2 were enriched in the CSCs microenvironment, and could recruit macrophages polarized to the immune-suppressive M2 phenotype (Wu et al., 2010; Zhou et al., 2015).”
BackgroundKondo, T. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.003 · Cited by 43
Macrophage/microglia-derived IL-1β induces glioblastoma growth via the STAT3/NF-κB pathway
Kai, K., Komohara, Y., Esumi, S., Fujiwara, Y., Yamamoto, T., Uekawa, K., Ohta, K., Takezaki, T., Kuroda, J., Shinojima, N., et al. (2021) · Human Cell · doi:10.1007/s13577-021-00619-8 · Cited by 40
Bianconi, A., Aruta, G., Rizzo, F., Salvati, L. F., Zeppa, P., Garbossa, D., & Cofano, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084166 · Cited by 40
“Sci. 2022, 23, 4166 5 of 17 demonstrated again the prevalence of HSCs in TAM (CCR2+ CX3C1−) and the relatively low presence of resident macrophages (CCR2− CX3C1+) [12].”
BackgroundMolecular targeted therapy: A new avenue in glioblastoma treatment (Review)
Atat, O. E., Naser, R., Abdelkhalek, M., Abi‐Habib, R. J., & El‐Sibai, M. (2022) · Oncology Letters · doi:10.3892/ol.2022.13632 · Cited by 52
“For instance, GBM stem cells recruit macrophages and promote their transition from the antitumor (M1) to the pro‑tumor (M2) phenotype (281).”
Induction of protumoral CD 11chigh macrophages by glioma cancer stem cells through GM ‐ CSF
Kokubu, Y., Tabu, K., Muramatsu, N., Wang, W., Murota, Y., Nobuhisa, I., Jinushi, M., & Taga, T. (2016) · Genes to Cells · doi:10.1111/gtc.12333 · Cited by 42
Bassoy, E. Y., Kasahara, A., Chiusolo, V., Jacquemin, G., Boydell, E., Zamorano, S., Riccadonna, C., Pellegatta, S., Hulo, N., Dutoit, V., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201695429 · Cited by 38
“Moreover, it was recently reported that GSC have immunosuppressive action through the polarization of the tumor-associated macrophages and the activation of myeloid suppressor cells (Wu et al , 2010; Zhou et al , 2015; Otvos et al , 2016).”
Tumor‑associated macrophages recruited by periostin in intrahepatic cholangiocarcinoma stem cells
Zeng, J., Liu, Z., Sun, S., Xie, J., Cao, L., Lv, P., Nie, S., Zhang, B., Xie, B., Peng, S., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8372 · Cited by 47
Cao, M., Chen, L., Dang, W., Zhang, X. C., Zhang, X., Shi, Y., Yao, X., Li, Q., Zhu, J., Lin, Y. Q., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.11.016 · Cited by 36
Extracellular vesicle-cell adhesion molecules in tumours: biofunctions and clinical applications
Lin, W., Fang, J., Wei, S., He, G., Liu, J., Li, X., Peng, X., Dai, L., Yang, S., Li, X., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01236-8 · Cited by 45
“These EVs activated the AKT and STAT3 signalling pathways, attracting myeloid-derived suppressor cells (MDSCs) and forming PMNs in the lung [127].”
BackgroundFernando, N., Natoli, R., Valter, K., Provis, J. M., & Rutar, M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0514-x · Cited by 41
“6a), which co-localises with IBA1 [56–58].”
HMGA 2 promotes glioma invasion and poor prognosis via a long‐range chromatin interaction
Zhang, S., Zhang, H., & Yu, L. (2018) · Cancer Medicine · doi:10.1002/cam4.1534 · Cited by 39
CD48 is a key molecule of immunomodulation affecting prognosis in glioma
Zou, C., Zhu, C. Y., Guan, G., Guo, Q., Liu, T., Shen, S., Yan, Z., Xu, X., Lin, Z., Chen, L., et al. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s198762 · Cited by 34
“It has been reported that TAMs interact with glioma stem cells to promote tumor progression and immunosuppression.(6,7) In addition, immune checkpoints play a significant role in suppressing the antitumor immune response.”
BackgroundFurudate, S., Fujimura, T., Kambayashi, Y., Kakizaki, A., Hidaka, T., & Aiba, S. (2017) · Anticancer Research · doi:10.21873/anticanres.11714 · Cited by 42
Macrophages-stimulated PRMT1-mediated EZH2 methylation promotes breast cancer metastasis
Li, Z., Wang, D., Wang, W., Chen, X., Tang, A., Hou, P., Li, M., Zheng, J., & Bai, J. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.037 · Cited by 37
Extracellular Vesicles and Cancer Stem Cells in Tumor Progression: New Therapeutic Perspectives
Scioli, M. G., Terriaca, S., Fiorelli, E., Storti, G., Fabbri, G., Cervelli, V., & Orlandi, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910572 · Cited by 41
Nanobiotechnology-based treatment strategies for malignant relapsed glioma
Qiu, Q., Ding, X., Chen, J., Chen, S., & Wang, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.016 · Cited by 39
Microglia–T cell conversations in brain cancer progression
Mirzaei, R., & Yong, V. W. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.08.006 · Cited by 37
Cell–cell communication in kidney fibrosis
He, M., Liu, Z., Li, L., & Liu, Y. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfad257 · Cited by 41
Thenuwara, G., Javed, B., Singh, B., & Tian, F. (2024) · Sensors · doi:10.3390/s24092865 · Cited by 43
Yang, Y., Jin, X., Xie, Y., Ning, C., Ai, Y., Wei, H., Xu, X., Ge, X., Yi, T., Huang, Q., et al. (2024) · Theranostics · doi:10.7150/thno.93473 · Cited by 39
Loss of periostin ameliorates adipose tissue inflammation and fibrosis in vivo
Nakazeki, F., Nishiga, M., Horie, T., Nishi, H., Nakashima, Y., Baba, O., Kuwabara, Y., Nishino, T., Nakao, T., Ide, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27009-9 · Cited by 39
Cho, H. R., Jeon, H., Park, C., Park, S., & Choi, S. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-34242-9 · Cited by 34
Targeting the Complement Pathway in Malignant Glioma Microenvironments
Zhu, H., Yu, X., Zhang, S., & Shu, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.657472 · Cited by 46
“GSCs was firstly identified by Singh, SK, and Houman in 2003 (Hemmati et al., 2003; Singh et al., 2003, 2004) and interacts with differential glioma cells, TAMs and hypoxic conditions of glioma microenvironments (Zhou et al., 2015; Shi et al., 2017; Man et al., 2018; Wang et al., 2018).”
BackgroundOld Stars and New Players in the Brain Tumor Microenvironment
Parmigiani, E., Scalera, M., Mori, E., Tantillo, E., & Vannini, E. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.709917 · Cited by 35
“Multiple mechanisms inducing TAMs education have been described and these include tumor-released cytokines (Komohara et al., 2008; Zhou et al., 2015; Kloepper et al., 2016; De Boeck et al., 2020), metabolites (Colegio et al., 2014; Shen et al., 2016; Takenaka et al., 2019) and extracellular…”
BackgroundSuperenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling
Lee, D., Gimple, R. C., Wu, X., Prager, B. C., Qiu, Z., Wu, Q., Daggubati, V., Mariappan, A., Gopalakrishnan, J., Sarkisian, M. R., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163592 · Cited by 37
Bianconi, A., Palmieri, G., Aruta, G., Monticelli, M., Zeppa, P., Tartara, F., Melcarne, A., Garbossa, D., & Cofano, F. (2023) · Biomedicines · doi:10.3390/biomedicines11061520 · Cited by 36
Cancer stem cells and their vascular niche: Do they benefit from each other?
Ping, Y., Zhang, X., & Bian, X. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.010 · Cited by 38
Zhou, Y., Meng, X., He, W., Li, X., Zhao, R., Dong, C., Yuan, D., Yang, J., Zhang, R., Shi, G., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac063 · Cited by 34
Zhong, H., Zhou, S., Yin, S., Qiu, Y., Liu, B., & Yu, H. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.014 · Cited by 45
“Similarly, POSTN derived from CSCs in GBM increases the quantity of M2-TAMs in tumors by recruiting monocyte-derived macrophages form peripheral blood through the integrin a v b 3 [44].”
Co-evolution of glioma and immune microenvironment
Elguindy, M. M., Young, J. S., Ho, W. S., & Lu, R. O. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009175 · Cited by 42
“57 Additionally, a gain- of-function screen of epigenetic regulators of GSC renewal identified the circadian regulator circadian locomotor output cycles kaput (CLOCK) as an important candidate for stem cell maintenance and modulation of the immune microenvironment.”
Zhang, H., Zhang, W., Sun, X., Dang, R., Zhou, R., Bai, H., Ben, J., Zhu, X., Zhang, Y., Yang, Q., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10318 · Cited by 36
“In GBM, TAMs can constitute up to 30% of the tumor mass [36] and, consistent with our observation that SR-A1 expression increased with glioma grade, are reportedly less abundant in lower grade gliomas.”
Metadata
- Authors
- Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., Rich, J. N., & Bao, S.
- Affiliations
- Cleveland Clinic (US)
- University Hospitals Cleveland Medical Center (US)
- Duke Medical Center (US)
- Corresponding author
- Bao, Shideng
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2015-01-12
- Volume
- 17
- Issue
- 2
- Pages
- 170-182
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC4312504
- OpenAlex
- W2073586533
- Cited by
- 940
- References
- 67
- Citations by year
- 2026: 29 · 2025: 74 · 2024: 93 · 2023: 101 · 2022: 118 · 2021: 117 · 2020: 93 · 2019: 82 · 2018: 71 · 2017: 81 · 2016: 50 · 2015: 30
- FWCI
- 38.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Cleveland Clinic
- National Institutes of Health (1r01ns071996-01a1)
- National Institute of General Medical Sciences (T32GM007250)
- National Institute of Allergy and Infectious Diseases (T32AI089474)
- National Institute of Neurological Disorders and Stroke (R01-NS071996, R01NS070315)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- periostin, glioblastoma, glioma stem cells, tumour-associated macrophages, M2 macrophages, macrophage recruitment, integrin αvβ3, RGD peptide, monocyte-derived macrophages, tumor microenvironment, tumor growth, therapeutic target
- MeSH terms
- Animals, Brain Neoplasms, Cell Count, Chemotactic Factors, Female, Fluorescent Antibody Technique, Glioblastoma, Humans, Luminescent Measurements, Macrophages, Mice, Inbred C57BL, Monocytes, Neoplastic Stem Cells, Signal Transduction, Cell Adhesion Molecules, Survival Analysis, Gene Silencing, Xenograft Model Antitumor Assays, RNA, Small Interfering, Integrin alphaVbeta3, Cell Line, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.